Order Article Reprints

Profire B-Ș, Lupașcu FG, Sava A, Turin-Moleavin I-A, Bejan D, Stătescu C, Șorodoc V, Sascău R-A, Șorodoc L, Pinteala M, et al. SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics. 2025; 17(8):969. https://doi.org/10.3390/pharmaceutics17080969

Profire, Bianca-Ștefania, Florentina Geanina Lupașcu, Alexandru Sava, Ioana-Andreea Turin-Moleavin, Dana Bejan, Cristian Stătescu, Victorița Șorodoc, Radu-Andy Sascău, Laurențiu Șorodoc, Mariana Pinteala, and et al. 2025. "SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy" Pharmaceutics 17, no. 8: 969. https://doi.org/10.3390/pharmaceutics17080969

Profire, B.-Ș., Lupașcu, F. G., Sava, A., Turin-Moleavin, I.-A., Bejan, D., Stătescu, C., Șorodoc, V., Sascău, R.-A., Șorodoc, L., Pinteala, M., & Profire, L. (2025). SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics, 17(8), 969. https://doi.org/10.3390/pharmaceutics17080969